Contact our team to schedule a time to meet during Access.
Biostatistics
The value of your data may be greater than you think. Unexplored trial or observational data may contain a goldmine of information to support your asset. You can develop insights into the patient experience by linking patient-reported outcomes with clinician-reported outcomes. It's possible to examine if and why treatment responses vary over time and across disease subtypes. Or you can determine if your missing data has a hidden meaning. Our statisticians can help you by applying statistical analysis methods and tools to support your outcomes research, health economics, and epidemiology and safety activities.
The RTI team have been wonderful partners to work with. They have repeatedly elevated the quality of work our team is able to present to cross functional teams and at scientific conferences. It is truly a pleasure to work with them and I look forward to many years of collaboration.
Services
Our team can deliver expert statistical support across all phases of clinical development, helping you design robust studies, analyze complex data, and generate evidence that meets regulatory and market access requirements. We combine scientific rigor with strategic insight to transform data into clear, actionable results that drive decision-making.
Database Studies
Leverage databases for health economic and pharmacoepidemiology research, enhancing safety assessments, and treatment effectiveness studies
Clinical Trial Data Analysis
Unlock the full potential of your clinical trial data by transforming complex datasets into clear, compelling insights that drive regulatory success and market access
Health-Related Quality of Life Analysis
Patient-centered measures of how an individual's physical, mental, emotional, and social well-being is affected by a medical condition or its treatment
Q-TWiST
Quality-adjusted Time Without Symptoms or Toxicity analysis helps quantify the trade-off between treatment efficacy and adverse effects
Cross-Sectional Surveys
Capture current disease prevalence, treatment modalities, and risk factors to enrich your real-world evidence for dossiers and support regulatory applications
Longitudinal Surveys
Leverage the power of longitudinal studes to understand changes in health, treatment response, and real-world outcomes over time
Statistical Analysis
Data analysis and visualization that can help strengthen your pharma or medical technology product development
Post-Authorization Studies
Strengthen safety, validate efficacy, and fulfill regulatory obligations with post-authorization studies that help you sustain market success
Site-Based Studies
Combine the rigor of in-person clinical assessments with deep patient insights gathered through structured surveys
External Control Arm Analysis
Use real-world evidence to efficiently and credibly evaluate novel treatments
Protocol Development
Ensure rigorous scientific validity, seamless regulatory alignment, and operational efficiency from day one
Causal Inference
Apply the target trial emulation framework to tackle challenges of analyzing RWD
Oct 26 - 28, '26
Join us for our presentation at this year's WODC EU and meet our team at booth #315.
Nov 8 - 11, '26
Bruno-Kreisky-Platz 1
1220 Vienna
Austria
We are pleased to be a year-round sponsor of ISPOR. Our team will attend, speak, and present in Vienna—see details here.